1800 202 8726
Inadequate & repeat biopsy

Changing Technique — for the Repeat Biopsy

When a biopsy comes back inconclusive, the question is not just whether to repeat it — it is whether the same technique will give a different answer. Understanding the escalation ladder helps you have a clearer conversation with your oncologist.

Medically reviewed by Dr. Muralidhar Muddusetty, Surgical Oncologist, MBBS (AIIMS) · MS Surgery (AIIMS) · DNB Surg Onc · MRCS (Edinburgh) · Last reviewed September 2026

  • Each technique collects different material — FNAC takes individual cells. Core biopsy takes small tissue cylinders with their structure intact. Excision removes the whole lump.
  • The first result tells you what to try next — Your team reviews why the first sample was inconclusive before deciding whether to repeat the same method or move to the next step.
  • Better guidance can sometimes fix the problem — Adding imaging guidance on the repeat — ultrasound or CT — sometimes resolves the question without escalating to a more invasive technique.
  • The decision belongs to your treating team — The right technique depends on the lesion, its location, and what the previous result showed — factors only your oncologist and pathologist can weigh.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Yes — the technique often does need to change. When FNAC gives inconclusive results, core needle biopsy provides the tissue architecture a pathologist needs to reach a diagnosis. When core biopsy is still insufficient, excision biopsy removes the whole lesion. Your oncologist decides which step fits based on what the first result showed.

Why does the technique matter on a repeat biopsy?

Each biopsy technique collects something different. FNAC draws individual cells — useful for cysts and superficial lumps, but it gives no information about how those cells are arranged in tissue. Core needle biopsy takes small cylinders of tissue that preserve their structure. Excision removes the whole lump.

An inconclusive result does not mean the first procedure failed. Sample quality depends on the target, its position, and whether imaging was used to guide the needle. ESMO guidance recommends moving to core biopsy when cytology is inconclusive, because tissue cores also support the receptor and molecular tests needed before any treatment decision is made.

What to ask before agreeing to a repeat biopsy

  • Why was the first sample inconclusive — too few cells, wrong area, or tissue that could not be classified?
  • Would image guidance alone fix the problem, or does the technique itself need to change?
  • If core biopsy is recommended, will it be done with ultrasound or CT guidance?
  • Is excision being considered, and would it serve as both diagnosis and treatment in one step?
  • How long will the repeat result take, and will additional tests be run on the same sample?
  • What is the plan if the repeat biopsy is also inconclusive?

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

FNAC, core needle biopsy, and excision compared

FeatureFNACCore needle biopsyExcision biopsy
What is collectedIndividual cells (cytology)Tissue cores with structure intact (histology)Whole lesion (histology)
ProcedureThin needle, no cutSlightly thicker needle, small nickSurgical cut, stitches needed
AnaestheticUsually noneLocal anaestheticLocal or general anaesthetic
Shows tissue architecture?NoYesYes
Can run molecular tests?SometimesUsually yesYes
When it is consideredFirst-line for superficial lumps and cystsAfter inconclusive FNACAfter inconclusive core, or for small removable lesions

Did you know?

When cytology is inconclusive, ESMO guidance recommends moving to core needle biopsy rather than repeating FNAC. Tissue cores preserve the structural arrangement of cells — and that is also what is needed to run receptor and molecular tests before most treatment decisions can be made.

Getting to histology without surgery is what makes core biopsy the essential middle step.

Source: ESMO Clinical Practice Guidelines

The escalation ladder, step by step

When is a repeat FNAC the right call?

A repeat FNAC using the same method is reasonable when the first sample was technically inadequate — the needle missed the target, or the sample was not prepared correctly before it reached the laboratory. It is less useful when cells were present but could not be classified, because FNAC cannot show the tissue architecture that classification requires. In those cases, moving to core biopsy is more likely to give a conclusive result.

When should FNAC be upgraded to core needle biopsy?

Core needle biopsy is usually the next step when FNAC has been inconclusive more than once, when the lesion is solid rather than a cyst, or when receptor or molecular testing is needed and cytology cannot support it. It preserves the structural arrangement of cells, which gives the pathologist the context to make a diagnosis that FNAC cannot provide. ESMO guidance recommends it as the preferred route to histology when cytology has been inconclusive.

When should core needle biopsy be upgraded to excision?

Excision is considered when core biopsy is inconclusive and imaging remains suspicious, or when there is a discordance between what the core result says and what the scan shows. It is also appropriate when the lesion is small enough that removing it whole serves as both diagnosis and treatment. Your surgeon and oncologist decide together whether excision is the right next step, weighing the benefit against the additional invasiveness.

Does adding image guidance change the technique decision?

Yes — significantly. Ultrasound or CT guidance allows the needle to be placed precisely into the target, reducing the chance of sampling the wrong area. If the first biopsy was done freehand and the repeat will be image-guided, that change alone may resolve the question without escalating to a more invasive technique. Ask specifically whether the first biopsy used imaging guidance, and whether the repeat will.

What does discordant mean, and why does it trigger escalation?

A discordant result is one where the biopsy says one thing and the imaging says another — for example, the scan suggests a tumour but the core biopsy comes back as normal tissue. Discordance usually means the needle missed the target, not that there is nothing there. NCCN guidance identifies discordance as a reason to escalate to excision rather than accepting a benign core result when imaging remains suspicious.

Explore 112 more Markers, Molecular Testing and Test Accuracy topics

HUB — How Accurate Is a Biopsy? Repeats, Errors and Second Opinions

HUB — IHC and Molecular Markers on a Biopsy

HUB — Labs, Slides and Second Opinions on a Biopsy

All Markers, Molecular Testing and Test Accuracy →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

If my FNAC was inconclusive, does that automatically mean I need a core biopsy?

Not automatically — it depends on why the FNAC was inconclusive. If the sample was technically inadequate, a repeat FNAC with image guidance may be enough. If cells were present but could not be classified, core biopsy is usually the next step, because it gives tissue with its architecture intact, which cytology cannot provide. Your oncologist reviews the pathology report and the imaging together before recommending anything.

Can I ask for excision biopsy straight away to avoid more procedures?

You can raise it, and your oncologist will consider it. Excision is surgery and carries risks including anaesthetic, scarring, and recovery time. For most solid lumps, core biopsy resolves the diagnostic question without those risks. Where excision makes sense — for small lesions where removal also treats the problem — your surgeon will usually suggest it. Asking is reasonable; the answer depends on what the previous result showed and where the lump is.

Does changing the technique mean the first biopsy was wasted?

No. The first result contributed information even if it was inconclusive. It narrows down the possibilities, sometimes rules out the most serious concerns, and tells your team what a less invasive approach could not show. Pathology is often a process of elimination. The next step is chosen because of what the first result showed, not despite it.

How long will a core biopsy result take to come back?

A standard histology report usually takes one to two weeks from when the laboratory receives the sample. If additional staining or molecular testing is needed — which is common when earlier sampling was inconclusive — it can take longer. Ask your team when the sample will be sent and when you should expect a result, so you are not waiting without a timeline.

Will I need general anaesthetic for the repeat biopsy?

FNAC and core needle biopsy are usually done under local anaesthetic as outpatient procedures. Excision biopsy may require a general anaesthetic depending on where the lump is and how deep it sits, though some are done under local anaesthetic. Your surgeon will explain what the specific procedure involves and what kind of anaesthetic is planned before you agree to go ahead.

Is it reasonable to get a second opinion before deciding which technique to use?

Yes, and many oncologists welcome it. A second opinion on the original pathology slides and the imaging can clarify whether the inconclusive result reflects a sampling problem or a genuinely difficult lesion. That distinction matters for deciding whether to repeat the same method with better technique or escalate. Ask your team for the pathology report and imaging to take to a second centre.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation